Spontaneous Remission of Epstein-Barr Virus-Negative Non-Hodgkin's Lymphoma after Withdrawal of Cyclosporine in a Patient with Refractory Anemia

International Journal of Hematology

Volumn 79, Issue 2, 2004, Pages 161-164

  Ogata, Masao ^a   Kikuchi, Hiroshi ^a   Ono, Keiji ^a   Ohtsuka, Eiichi ^a   Gamachi, Ayako ^a   Kashima, Kenji ^a   Nasu, Masaru ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Cyclosporine; Epstein Barr virus; Non Hodgkin's lymphoma; Refractory anemia; Spontaneous remission

Indexed keywords

CYCLOSPORIN A;

AGED; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BONE MARROW EXAMINATION; CASE REPORT; DRUG WITHDRAWAL; ENDOSCOPY; EPIGASTRIC PAIN; EPSTEIN BARR VIRUS; GASTRECTOMY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IN SITU HYBRIDIZATION; MALE; NONHODGKIN LYMPHOMA; PANCYTOPENIA; REFRACTORY ANEMIA; REMISSION; STOMACH BIOPSY; STOMACH ULCER; VIRUS DETECTION;

EID: 1442334988     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.03095     Document Type: Article

References (16)

1. Starzl TE, Nalesnik MA, Porter KA, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet. 1984;1:583-587.
2. Kamel OW, van de Rijn M, Weiss LM, et al. Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med. 1993;328:1317-1321.
3. Baird RD, van Zyl-Smit RN, Dilke T, Scott SE, Rassam SM. Spontaneous remission of low-grade B-cell non-Hodgkin's lymphoma following withdrawal of methotrexate in a patient with rheumatoid arthritis: case report and review of the literature. Br J Haematol. 2002;118:567-568.
4. Mariette X, Cazals-Hatem D, Warszawki J, Liote F, Balandraud N, Sibilia J, and the investigators of the Club Rhumatismes et Inflammation. Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood. 2002;99: 3909-3915.
5. Dawson TM, Starkebaum G, Wood BL, Willkens RF, Gown AM. Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series. J Rheumatol. 2001;28:47-53.
6. Dorr V, Doolittle G, Woodroof J. First report of a B cell lymphoproliferative disorder arising in a patient treated with immune suppressants for severe aplastic anemia. Am J Hematol. 1996;52: 108-113.
7. Cliff S, Pettengell R, Gharge S, Marsden RA. B-cell lymphoma developing in a patient on cyclosporin for recalcitrant psoriasis. Br J Dermatol. 1999;140:763-765.
8. Larvol L, Soule JC, Le Tourneau A. Reversible lymphoma in the setting of azathioprine therapy for Crohn's disease. N Engl J Med. 1994;331:883-884.
9. Farrell RJ, Ang Y, Kileen P, et al. Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low. Gut. 2000;47: 514-519.
10. Banks PM, Witrak GA, Conn DL. Lymphoid neoplasia following connective tissue disease. Mayo Clin Proc. 1979;54:104-108.
11. Moder KG, Tefferi A, Cohen MD, Menke DM, Luthra HS. Hematologic malignancies and the use of methotrexate in rheumatoid arthritis: a retrospective study. Am J Med. 1995;99:276-281.
12. Shiroky JB, Frost A, Skelton JD, Haegert DG, Newkirk MM, Neville C. Complications of immunosuppression associated with weekly low dose methotrexate. J Rheumatol. 1991;18:1172-1175.
13. Shiroky JB, Newkirk MM. Reversible lymphomas. N Engl J Med. 1993;329:1657-1658.
14. Jonasova A, Neuwirtova R, Cermak J, et al. Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow. Br J Haematol. 1998;100:304-309.
15. Shimamoto T, Iguchi T, Ando K, et al. Successful treatment with cyclosporin A for myelodysplastic syndrome with erythroid hypoplasia associated with T-cell receptor gene rearrangements. Br J Haematol. 2001;114:358-361.
16. Enright H, Jacob HS, Vercellotti G, Howe R, Belzer M, Miller W. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy. Br J Haematol. 1995;91:403-408.